The UK was the first country in the world to license a drug that uses the genome-editing approach CRISPR (see BioNews 1216).
RoslinCT, the contract development and manufacturing organisation arm of the Roslin Institute, Edinburgh, has been chosen to manufacture the drug treatment.
The Roslin Institute created Dolly the sheep in 1997, the first mammal to be cloned from an adult cell (see BioNews 1131).
Read more on this story at Fierce Biotech.
